SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
Clinical trial NCT03230747 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03230747
- Sponsor
- Edwards Lifesciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-14
- Primary completion
- 2021-06-16
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.